Articles

Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy

Institute of Immunity and Transplantation, UCL Division of Infection and Immunity, University College London, Royal Free Hospital London
Institute of Immunity and Transplantation, UCL Division of Infection and Immunity, University College London, Royal Free Hospital London
Institute of Immunity and Transplantation, UCL Division of Infection and Immunity, University College London, Royal Free Hospital London
Institute of Immunity and Transplantation, UCL Division of Infection and Immunity, University College London, Royal Free Hospital London
Institute of Immunity and Transplantation, UCL Division of Infection and Immunity, University College London, Royal Free Hospital London
Institute of Immunity and Transplantation, UCL Division of Infection and Immunity, University College London, Royal Free Hospital London
Institute of Immunity and Transplantation, UCL Division of Infection and Immunity, University College London, Royal Free Hospital London
Institute of Immunity and Transplantation, UCL Division of Infection and Immunity, University College London, Royal Free Hospital London;Department of Haematology, Cancer Institute, University College London, UK
Institute of Immunity and Transplantation, UCL Division of Infection and Immunity, University College London, Royal Free Hospital London
Institute of Immunity and Transplantation, UCL Division of Infection and Immunity, University College London, Royal Free Hospital London
Vol. 101 No. 4 (2016): April, 2016 https://doi.org/10.3324/haematol.2015.132712